转化生长因子-β和骨形态遗传蛋白信号通路在病理性心脏缩中
Jing Wen1, Guixiang Liu1, Mingjie Liu2
1Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
病理性心脏缩是心力衰竭的主要危险因素. 本综述探讨了分子标,重点关注TGF-β和BMP信号传递,以改善心脏缩治疗.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 病理生理学 病理生理学
背景情况:
- 病态心脏缩是心力衰竭和突然死亡的重要危险因素.
- 目前治疗心脏缩的治疗方法有效性有限,主要是治疗症状.
- 了解驱动心脏缩的分子机制对于开发有效疗法至关重要.
研究的目的:
- 审查参与心脏缩病变的活性物质和信号通路.
- 专注于转化生长因子-β (TGF-β) 和骨形态遗传蛋白 (BMP) 信号传导的作用.
- 确定潜在的分子标,用于精确干预心脏缩.
主要方法:
- 文献综述总结了关于心脏缩的研究.
- 分析涉及心脏缩发展的信号通路.
- 确定潜在的治疗向的关键分子.
主要成果:
- 多种活性物质和信号通路有助于心脏缩.
- TGF-β和BMP信号通路在心脏缩的进展中起着关键作用.
- 特定的信号分子显示出作为分子干预的目标的潜力.
结论:
- 阐明分子通路是推进心脏缩治疗的关键.
- TGF-β和BMP信号传递为新型治疗策略提供了有希望的目标.
- 识别具有临床价值的信号分子可以导致精确的治疗和改善患者的治疗结果.
更多相关视频
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
相关概念视频
TGF - β Signaling Pathway
Pathophysiology of Heart Failure
Regulation of Angiogenesis and Blood Supply
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
